nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER2—Ovarian Infertility Genes—DAZL—testicular cancer	0.153	0.496	CbGpPWpGaD
Misoprostol—PTGER4—G alpha (s) signalling events—INSL3—testicular cancer	0.0274	0.089	CbGpPWpGaD
Misoprostol—Dinoprostone—HPGDS—testicular cancer	0.0246	1	CrCbGaD
Misoprostol—PTGER2—G alpha (s) signalling events—INSL3—testicular cancer	0.0225	0.0731	CbGpPWpGaD
Misoprostol—PTGER2—female gonad—testicular cancer	0.0169	0.141	CbGeAlD
Misoprostol—PTGER4—female gonad—testicular cancer	0.0166	0.138	CbGeAlD
Misoprostol—PTGER2—testis—testicular cancer	0.015	0.125	CbGeAlD
Misoprostol—PTGER4—testis—testicular cancer	0.0148	0.122	CbGeAlD
Misoprostol—PTGER3—female gonad—testicular cancer	0.0141	0.117	CbGeAlD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.013	0.0424	CbGpPWpGaD
Misoprostol—PTGER3—testis—testicular cancer	0.0125	0.104	CbGeAlD
Misoprostol—PTGER2—lymph node—testicular cancer	0.0109	0.0903	CbGeAlD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.0107	0.0348	CbGpPWpGaD
Misoprostol—PTGER4—lymph node—testicular cancer	0.0107	0.0887	CbGeAlD
Misoprostol—PTGER4—GPCR ligand binding—INSL3—testicular cancer	0.00994	0.0323	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00989	0.0321	CbGpPWpGaD
Misoprostol—PTGER3—lymph node—testicular cancer	0.00906	0.0751	CbGeAlD
Misoprostol—PTGER2—GPCR ligand binding—INSL3—testicular cancer	0.00816	0.0265	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—INSL3—testicular cancer	0.00753	0.0245	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—INSL3—testicular cancer	0.00562	0.0183	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—INSL3—testicular cancer	0.0051	0.0166	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—INSL3—testicular cancer	0.00461	0.015	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—INSL3—testicular cancer	0.00426	0.0138	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—INSL3—testicular cancer	0.00419	0.0136	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—INSL3—testicular cancer	0.00386	0.0126	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—INSL3—testicular cancer	0.00301	0.00979	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—INSL3—testicular cancer	0.00247	0.00804	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—INSL3—testicular cancer	0.00228	0.00742	CbGpPWpGaD
Misoprostol—Dizziness—Vinblastine—testicular cancer	0.00111	0.00203	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00111	0.00202	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.00109	0.002	CcSEcCtD
Misoprostol—Myalgia—Cisplatin—testicular cancer	0.00109	0.002	CcSEcCtD
Misoprostol—Feeling abnormal—Dactinomycin—testicular cancer	0.00109	0.002	CcSEcCtD
Misoprostol—Nausea—Chlorambucil—testicular cancer	0.00109	0.00199	CcSEcCtD
Misoprostol—Anxiety—Cisplatin—testicular cancer	0.00109	0.00199	CcSEcCtD
Misoprostol—Anaemia—Etoposide—testicular cancer	0.00109	0.00199	CcSEcCtD
Misoprostol—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00108	0.00198	CcSEcCtD
Misoprostol—Dyspnoea—Ifosfamide—testicular cancer	0.00108	0.00198	CcSEcCtD
Misoprostol—Somnolence—Ifosfamide—testicular cancer	0.00108	0.00197	CcSEcCtD
Misoprostol—Vomiting—Vinblastine—testicular cancer	0.00107	0.00196	CcSEcCtD
Misoprostol—Breast disorder—Methotrexate—testicular cancer	0.00106	0.00193	CcSEcCtD
Misoprostol—Headache—Vinblastine—testicular cancer	0.00105	0.00193	CcSEcCtD
Misoprostol—Purpura—Doxorubicin—testicular cancer	0.00105	0.00192	CcSEcCtD
Misoprostol—Abdominal pain—Dactinomycin—testicular cancer	0.00105	0.00192	CcSEcCtD
Misoprostol—Body temperature increased—Dactinomycin—testicular cancer	0.00105	0.00192	CcSEcCtD
Misoprostol—Fatigue—Ifosfamide—testicular cancer	0.00105	0.00191	CcSEcCtD
Misoprostol—Anaphylactic shock—Cisplatin—testicular cancer	0.00105	0.00191	CcSEcCtD
Misoprostol—Oedema—Cisplatin—testicular cancer	0.00105	0.00191	CcSEcCtD
Misoprostol—Hypersensitivity—Bleomycin—testicular cancer	0.00105	0.00191	CcSEcCtD
Misoprostol—Infection—Cisplatin—testicular cancer	0.00104	0.0019	CcSEcCtD
Misoprostol—Constipation—Ifosfamide—testicular cancer	0.00104	0.0019	CcSEcCtD
Misoprostol—Pain—Ifosfamide—testicular cancer	0.00104	0.0019	CcSEcCtD
Misoprostol—Loss of consciousness—Etoposide—testicular cancer	0.00103	0.00189	CcSEcCtD
Misoprostol—Thrombocytopenia—Cisplatin—testicular cancer	0.00103	0.00187	CcSEcCtD
Misoprostol—Asthenia—Bleomycin—testicular cancer	0.00102	0.00186	CcSEcCtD
Misoprostol—Dehydration—Epirubicin—testicular cancer	0.00102	0.00186	CcSEcCtD
Misoprostol—Hypertension—Etoposide—testicular cancer	0.00101	0.00185	CcSEcCtD
Misoprostol—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.00101	0.00185	CcSEcCtD
Misoprostol—Hyperhidrosis—Cisplatin—testicular cancer	0.00101	0.00185	CcSEcCtD
Misoprostol—Feeling abnormal—Ifosfamide—testicular cancer	0.001	0.00183	CcSEcCtD
Misoprostol—Chest pain—Etoposide—testicular cancer	0.001	0.00183	CcSEcCtD
Misoprostol—Nausea—Vinblastine—testicular cancer	0.001	0.00183	CcSEcCtD
Misoprostol—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000993	0.00182	CcSEcCtD
Misoprostol—Breast disorder—Epirubicin—testicular cancer	0.000989	0.00181	CcSEcCtD
Misoprostol—Hypotension—Cisplatin—testicular cancer	0.000978	0.00179	CcSEcCtD
Misoprostol—Hypersensitivity—Dactinomycin—testicular cancer	0.000977	0.00178	CcSEcCtD
Misoprostol—Confusional state—Etoposide—testicular cancer	0.000967	0.00177	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—H2AFZ—testicular cancer	0.000964	0.00313	CbGpPWpGaD
Misoprostol—Abdominal pain—Ifosfamide—testicular cancer	0.00096	0.00176	CcSEcCtD
Misoprostol—Body temperature increased—Ifosfamide—testicular cancer	0.00096	0.00176	CcSEcCtD
Misoprostol—Anaphylactic shock—Etoposide—testicular cancer	0.000959	0.00175	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—STK11—testicular cancer	0.000959	0.00312	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000954	0.00174	CcSEcCtD
Misoprostol—Infection—Etoposide—testicular cancer	0.000953	0.00174	CcSEcCtD
Misoprostol—Asthenia—Dactinomycin—testicular cancer	0.000951	0.00174	CcSEcCtD
Misoprostol—Dysphagia—Epirubicin—testicular cancer	0.000946	0.00173	CcSEcCtD
Misoprostol—Dysuria—Methotrexate—testicular cancer	0.000945	0.00173	CcSEcCtD
Misoprostol—Dehydration—Doxorubicin—testicular cancer	0.000941	0.00172	CcSEcCtD
Misoprostol—Thrombocytopenia—Etoposide—testicular cancer	0.000939	0.00172	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000939	0.00172	CcSEcCtD
Misoprostol—Dyspnoea—Cisplatin—testicular cancer	0.000934	0.00171	CcSEcCtD
Misoprostol—Erectile dysfunction—Methotrexate—testicular cancer	0.000931	0.0017	CcSEcCtD
Misoprostol—Hyperhidrosis—Etoposide—testicular cancer	0.000927	0.0017	CcSEcCtD
Misoprostol—Breast disorder—Doxorubicin—testicular cancer	0.000915	0.00167	CcSEcCtD
Misoprostol—Bronchitis—Epirubicin—testicular cancer	0.000909	0.00166	CcSEcCtD
Misoprostol—Diarrhoea—Dactinomycin—testicular cancer	0.000907	0.00166	CcSEcCtD
Misoprostol—Pneumonia—Methotrexate—testicular cancer	0.000906	0.00166	CcSEcCtD
Misoprostol—Vomiting—Bleomycin—testicular cancer	0.000904	0.00165	CcSEcCtD
Misoprostol—Drowsiness—Methotrexate—testicular cancer	0.000901	0.00165	CcSEcCtD
Misoprostol—Hypotension—Etoposide—testicular cancer	0.000896	0.00164	CcSEcCtD
Misoprostol—Rash—Bleomycin—testicular cancer	0.000896	0.00164	CcSEcCtD
Misoprostol—Pain—Cisplatin—testicular cancer	0.000895	0.00164	CcSEcCtD
Misoprostol—Dermatitis—Bleomycin—testicular cancer	0.000895	0.00164	CcSEcCtD
Misoprostol—Hypersensitivity—Ifosfamide—testicular cancer	0.000895	0.00164	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—KITLG—testicular cancer	0.000887	0.00288	CbGpPWpGaD
Misoprostol—Dysuria—Epirubicin—testicular cancer	0.000884	0.00162	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000879	0.00161	CcSEcCtD
Misoprostol—Conjunctivitis—Methotrexate—testicular cancer	0.000876	0.0016	CcSEcCtD
Misoprostol—Dysphagia—Doxorubicin—testicular cancer	0.000875	0.0016	CcSEcCtD
Misoprostol—Asthenia—Ifosfamide—testicular cancer	0.000871	0.00159	CcSEcCtD
Misoprostol—Feeling abnormal—Cisplatin—testicular cancer	0.000863	0.00158	CcSEcCtD
Misoprostol—Haematuria—Methotrexate—testicular cancer	0.000859	0.00157	CcSEcCtD
Misoprostol—Dyspnoea—Etoposide—testicular cancer	0.000855	0.00156	CcSEcCtD
Misoprostol—Somnolence—Etoposide—testicular cancer	0.000853	0.00156	CcSEcCtD
Misoprostol—Epistaxis—Methotrexate—testicular cancer	0.00085	0.00155	CcSEcCtD
Misoprostol—Pneumonia—Epirubicin—testicular cancer	0.000848	0.00155	CcSEcCtD
Misoprostol—Nausea—Bleomycin—testicular cancer	0.000844	0.00154	CcSEcCtD
Misoprostol—Drowsiness—Epirubicin—testicular cancer	0.000843	0.00154	CcSEcCtD
Misoprostol—Vomiting—Dactinomycin—testicular cancer	0.000843	0.00154	CcSEcCtD
Misoprostol—Bronchitis—Doxorubicin—testicular cancer	0.000841	0.00154	CcSEcCtD
Misoprostol—Rash—Dactinomycin—testicular cancer	0.000836	0.00153	CcSEcCtD
Misoprostol—Diarrhoea—Ifosfamide—testicular cancer	0.000831	0.00152	CcSEcCtD
Misoprostol—Body temperature increased—Cisplatin—testicular cancer	0.000828	0.00151	CcSEcCtD
Misoprostol—Fatigue—Etoposide—testicular cancer	0.000827	0.00151	CcSEcCtD
Misoprostol—Neuropathy peripheral—Epirubicin—testicular cancer	0.000826	0.00151	CcSEcCtD
Misoprostol—Pain—Etoposide—testicular cancer	0.00082	0.0015	CcSEcCtD
Misoprostol—Constipation—Etoposide—testicular cancer	0.00082	0.0015	CcSEcCtD
Misoprostol—Conjunctivitis—Epirubicin—testicular cancer	0.00082	0.0015	CcSEcCtD
Misoprostol—Urinary tract infection—Epirubicin—testicular cancer	0.00082	0.0015	CcSEcCtD
Misoprostol—Dysuria—Doxorubicin—testicular cancer	0.000818	0.0015	CcSEcCtD
Misoprostol—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000813	0.00149	CcSEcCtD
Misoprostol—Haematuria—Epirubicin—testicular cancer	0.000804	0.00147	CcSEcCtD
Misoprostol—Dizziness—Ifosfamide—testicular cancer	0.000803	0.00147	CcSEcCtD
Misoprostol—Epistaxis—Epirubicin—testicular cancer	0.000795	0.00145	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—H2AFZ—testicular cancer	0.000792	0.00257	CbGpPWpGaD
Misoprostol—Feeling abnormal—Etoposide—testicular cancer	0.000791	0.00144	CcSEcCtD
Misoprostol—Nausea—Dactinomycin—testicular cancer	0.000787	0.00144	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—STK11—testicular cancer	0.000787	0.00256	CbGpPWpGaD
Misoprostol—Pneumonia—Doxorubicin—testicular cancer	0.000785	0.00143	CcSEcCtD
Misoprostol—Gastrointestinal pain—Etoposide—testicular cancer	0.000784	0.00143	CcSEcCtD
Misoprostol—Drowsiness—Doxorubicin—testicular cancer	0.00078	0.00143	CcSEcCtD
Misoprostol—Visual impairment—Methotrexate—testicular cancer	0.000779	0.00142	CcSEcCtD
Misoprostol—Vomiting—Ifosfamide—testicular cancer	0.000772	0.00141	CcSEcCtD
Misoprostol—Hypersensitivity—Cisplatin—testicular cancer	0.000771	0.00141	CcSEcCtD
Misoprostol—Rash—Ifosfamide—testicular cancer	0.000766	0.0014	CcSEcCtD
Misoprostol—Dermatitis—Ifosfamide—testicular cancer	0.000765	0.0014	CcSEcCtD
Misoprostol—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000765	0.0014	CcSEcCtD
Misoprostol—Body temperature increased—Etoposide—testicular cancer	0.000758	0.00139	CcSEcCtD
Misoprostol—Abdominal pain—Etoposide—testicular cancer	0.000758	0.00139	CcSEcCtD
Misoprostol—Conjunctivitis—Doxorubicin—testicular cancer	0.000758	0.00139	CcSEcCtD
Misoprostol—Urinary tract infection—Doxorubicin—testicular cancer	0.000758	0.00139	CcSEcCtD
Misoprostol—Tinnitus—Methotrexate—testicular cancer	0.000754	0.00138	CcSEcCtD
Misoprostol—Asthenia—Cisplatin—testicular cancer	0.000751	0.00137	CcSEcCtD
Misoprostol—Haematuria—Doxorubicin—testicular cancer	0.000744	0.00136	CcSEcCtD
Misoprostol—Epistaxis—Doxorubicin—testicular cancer	0.000736	0.00134	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—H2AFZ—testicular cancer	0.000731	0.00238	CbGpPWpGaD
Misoprostol—Immune system disorder—Methotrexate—testicular cancer	0.000731	0.00134	CcSEcCtD
Misoprostol—Visual impairment—Epirubicin—testicular cancer	0.000729	0.00133	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—KITLG—testicular cancer	0.000728	0.00237	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—STK11—testicular cancer	0.000727	0.00236	CbGpPWpGaD
Misoprostol—Chills—Methotrexate—testicular cancer	0.000726	0.00133	CcSEcCtD
Misoprostol—Nausea—Ifosfamide—testicular cancer	0.000721	0.00132	CcSEcCtD
Misoprostol—Diarrhoea—Cisplatin—testicular cancer	0.000716	0.00131	CcSEcCtD
Misoprostol—Alopecia—Methotrexate—testicular cancer	0.000715	0.00131	CcSEcCtD
Misoprostol—Hypersensitivity—Etoposide—testicular cancer	0.000707	0.00129	CcSEcCtD
Misoprostol—Tinnitus—Epirubicin—testicular cancer	0.000706	0.00129	CcSEcCtD
Misoprostol—Asthenia—Etoposide—testicular cancer	0.000688	0.00126	CcSEcCtD
Misoprostol—Immune system disorder—Epirubicin—testicular cancer	0.000684	0.00125	CcSEcCtD
Misoprostol—Back pain—Methotrexate—testicular cancer	0.000681	0.00124	CcSEcCtD
Misoprostol—Chills—Epirubicin—testicular cancer	0.000679	0.00124	CcSEcCtD
Misoprostol—Arrhythmia—Epirubicin—testicular cancer	0.000676	0.00124	CcSEcCtD
Misoprostol—Visual impairment—Doxorubicin—testicular cancer	0.000675	0.00123	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—KITLG—testicular cancer	0.000672	0.00219	CbGpPWpGaD
Misoprostol—Alopecia—Epirubicin—testicular cancer	0.000669	0.00122	CcSEcCtD
Misoprostol—Vomiting—Cisplatin—testicular cancer	0.000666	0.00122	CcSEcCtD
Misoprostol—Rash—Cisplatin—testicular cancer	0.00066	0.00121	CcSEcCtD
Misoprostol—Dermatitis—Cisplatin—testicular cancer	0.00066	0.00121	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—FGFR3—testicular cancer	0.000659	0.00214	CbGpPWpGaD
Misoprostol—Diarrhoea—Etoposide—testicular cancer	0.000656	0.0012	CcSEcCtD
Misoprostol—Tinnitus—Doxorubicin—testicular cancer	0.000653	0.00119	CcSEcCtD
Misoprostol—Anaemia—Methotrexate—testicular cancer	0.000651	0.00119	CcSEcCtD
Misoprostol—Flatulence—Epirubicin—testicular cancer	0.000649	0.00119	CcSEcCtD
Misoprostol—Back pain—Epirubicin—testicular cancer	0.000637	0.00116	CcSEcCtD
Misoprostol—Dizziness—Etoposide—testicular cancer	0.000634	0.00116	CcSEcCtD
Misoprostol—Muscle spasms—Epirubicin—testicular cancer	0.000633	0.00116	CcSEcCtD
Misoprostol—Immune system disorder—Doxorubicin—testicular cancer	0.000633	0.00116	CcSEcCtD
Misoprostol—Chills—Doxorubicin—testicular cancer	0.000628	0.00115	CcSEcCtD
Misoprostol—Arrhythmia—Doxorubicin—testicular cancer	0.000626	0.00114	CcSEcCtD
Misoprostol—Nausea—Cisplatin—testicular cancer	0.000622	0.00114	CcSEcCtD
Misoprostol—Alopecia—Doxorubicin—testicular cancer	0.000619	0.00113	CcSEcCtD
Misoprostol—Vomiting—Etoposide—testicular cancer	0.00061	0.00111	CcSEcCtD
Misoprostol—Anaemia—Epirubicin—testicular cancer	0.000609	0.00111	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—KIT—testicular cancer	0.000605	0.00197	CbGpPWpGaD
Misoprostol—Rash—Etoposide—testicular cancer	0.000605	0.00111	CcSEcCtD
Misoprostol—Dermatitis—Etoposide—testicular cancer	0.000604	0.0011	CcSEcCtD
Misoprostol—Headache—Etoposide—testicular cancer	0.000601	0.0011	CcSEcCtD
Misoprostol—Flatulence—Doxorubicin—testicular cancer	0.000601	0.0011	CcSEcCtD
Misoprostol—Arthralgia—Methotrexate—testicular cancer	0.000599	0.0011	CcSEcCtD
Misoprostol—Chest pain—Methotrexate—testicular cancer	0.000599	0.0011	CcSEcCtD
Misoprostol—Myalgia—Methotrexate—testicular cancer	0.000599	0.0011	CcSEcCtD
Misoprostol—Syncope—Epirubicin—testicular cancer	0.000591	0.00108	CcSEcCtD
Misoprostol—Back pain—Doxorubicin—testicular cancer	0.00059	0.00108	CcSEcCtD
Misoprostol—Muscle spasms—Doxorubicin—testicular cancer	0.000586	0.00107	CcSEcCtD
Misoprostol—Confusional state—Methotrexate—testicular cancer	0.000579	0.00106	CcSEcCtD
Misoprostol—Loss of consciousness—Epirubicin—testicular cancer	0.000579	0.00106	CcSEcCtD
Misoprostol—Anaphylactic shock—Methotrexate—testicular cancer	0.000575	0.00105	CcSEcCtD
Misoprostol—Infection—Methotrexate—testicular cancer	0.000571	0.00104	CcSEcCtD
Misoprostol—Nausea—Etoposide—testicular cancer	0.00057	0.00104	CcSEcCtD
Misoprostol—Hypertension—Epirubicin—testicular cancer	0.000569	0.00104	CcSEcCtD
Misoprostol—Anaemia—Doxorubicin—testicular cancer	0.000563	0.00103	CcSEcCtD
Misoprostol—Thrombocytopenia—Methotrexate—testicular cancer	0.000563	0.00103	CcSEcCtD
Misoprostol—Chest pain—Epirubicin—testicular cancer	0.000561	0.00103	CcSEcCtD
Misoprostol—Arthralgia—Epirubicin—testicular cancer	0.000561	0.00103	CcSEcCtD
Misoprostol—Myalgia—Epirubicin—testicular cancer	0.000561	0.00103	CcSEcCtD
Misoprostol—Anxiety—Epirubicin—testicular cancer	0.000559	0.00102	CcSEcCtD
Misoprostol—Hyperhidrosis—Methotrexate—testicular cancer	0.000555	0.00102	CcSEcCtD
Misoprostol—Syncope—Doxorubicin—testicular cancer	0.000547	0.000999	CcSEcCtD
Misoprostol—Confusional state—Epirubicin—testicular cancer	0.000542	0.000991	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—FGFR3—testicular cancer	0.000541	0.00176	CbGpPWpGaD
Misoprostol—Anaphylactic shock—Epirubicin—testicular cancer	0.000538	0.000983	CcSEcCtD
Misoprostol—Oedema—Epirubicin—testicular cancer	0.000538	0.000983	CcSEcCtD
Misoprostol—Hypotension—Methotrexate—testicular cancer	0.000537	0.000981	CcSEcCtD
Misoprostol—Loss of consciousness—Doxorubicin—testicular cancer	0.000536	0.000979	CcSEcCtD
Misoprostol—Infection—Epirubicin—testicular cancer	0.000534	0.000976	CcSEcCtD
Misoprostol—Shock—Epirubicin—testicular cancer	0.000529	0.000967	CcSEcCtD
Misoprostol—Thrombocytopenia—Epirubicin—testicular cancer	0.000527	0.000962	CcSEcCtD
Misoprostol—Hypertension—Doxorubicin—testicular cancer	0.000526	0.000962	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000524	0.000957	CcSEcCtD
Misoprostol—Hyperhidrosis—Epirubicin—testicular cancer	0.00052	0.00095	CcSEcCtD
Misoprostol—Myalgia—Doxorubicin—testicular cancer	0.000519	0.000949	CcSEcCtD
Misoprostol—Chest pain—Doxorubicin—testicular cancer	0.000519	0.000949	CcSEcCtD
Misoprostol—Arthralgia—Doxorubicin—testicular cancer	0.000519	0.000949	CcSEcCtD
Misoprostol—Anxiety—Doxorubicin—testicular cancer	0.000517	0.000945	CcSEcCtD
Misoprostol—Dyspnoea—Methotrexate—testicular cancer	0.000512	0.000936	CcSEcCtD
Misoprostol—Somnolence—Methotrexate—testicular cancer	0.000511	0.000934	CcSEcCtD
Misoprostol—Dyspepsia—Methotrexate—testicular cancer	0.000506	0.000925	CcSEcCtD
Misoprostol—Hypotension—Epirubicin—testicular cancer	0.000502	0.000918	CcSEcCtD
Misoprostol—Confusional state—Doxorubicin—testicular cancer	0.000502	0.000917	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—FGFR3—testicular cancer	0.0005	0.00162	CbGpPWpGaD
Misoprostol—Anaphylactic shock—Doxorubicin—testicular cancer	0.000498	0.000909	CcSEcCtD
Misoprostol—Oedema—Doxorubicin—testicular cancer	0.000498	0.000909	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—KIT—testicular cancer	0.000497	0.00162	CbGpPWpGaD
Misoprostol—Fatigue—Methotrexate—testicular cancer	0.000495	0.000905	CcSEcCtD
Misoprostol—Infection—Doxorubicin—testicular cancer	0.000494	0.000903	CcSEcCtD
Misoprostol—Pain—Methotrexate—testicular cancer	0.000491	0.000898	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00049	0.000895	CcSEcCtD
Misoprostol—Shock—Doxorubicin—testicular cancer	0.00049	0.000895	CcSEcCtD
Misoprostol—Thrombocytopenia—Doxorubicin—testicular cancer	0.000487	0.00089	CcSEcCtD
Misoprostol—Hyperhidrosis—Doxorubicin—testicular cancer	0.000481	0.000879	CcSEcCtD
Misoprostol—Dyspnoea—Epirubicin—testicular cancer	0.000479	0.000876	CcSEcCtD
Misoprostol—Somnolence—Epirubicin—testicular cancer	0.000478	0.000874	CcSEcCtD
Misoprostol—Feeling abnormal—Methotrexate—testicular cancer	0.000474	0.000865	CcSEcCtD
Misoprostol—Dyspepsia—Epirubicin—testicular cancer	0.000473	0.000865	CcSEcCtD
Misoprostol—Gastrointestinal pain—Methotrexate—testicular cancer	0.00047	0.000859	CcSEcCtD
Misoprostol—Hypotension—Doxorubicin—testicular cancer	0.000465	0.00085	CcSEcCtD
Misoprostol—Fatigue—Epirubicin—testicular cancer	0.000464	0.000847	CcSEcCtD
Misoprostol—Pain—Epirubicin—testicular cancer	0.00046	0.000841	CcSEcCtD
Misoprostol—Constipation—Epirubicin—testicular cancer	0.00046	0.000841	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—KIT—testicular cancer	0.000459	0.00149	CbGpPWpGaD
Misoprostol—Abdominal pain—Methotrexate—testicular cancer	0.000454	0.00083	CcSEcCtD
Misoprostol—Body temperature increased—Methotrexate—testicular cancer	0.000454	0.00083	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000453	0.000829	CcSEcCtD
Misoprostol—Dyspnoea—Doxorubicin—testicular cancer	0.000444	0.000811	CcSEcCtD
Misoprostol—Feeling abnormal—Epirubicin—testicular cancer	0.000443	0.00081	CcSEcCtD
Misoprostol—Somnolence—Doxorubicin—testicular cancer	0.000442	0.000808	CcSEcCtD
Misoprostol—Gastrointestinal pain—Epirubicin—testicular cancer	0.00044	0.000804	CcSEcCtD
Misoprostol—Dyspepsia—Doxorubicin—testicular cancer	0.000438	0.000801	CcSEcCtD
Misoprostol—Fatigue—Doxorubicin—testicular cancer	0.000429	0.000784	CcSEcCtD
Misoprostol—Constipation—Doxorubicin—testicular cancer	0.000425	0.000778	CcSEcCtD
Misoprostol—Pain—Doxorubicin—testicular cancer	0.000425	0.000778	CcSEcCtD
Misoprostol—Body temperature increased—Epirubicin—testicular cancer	0.000425	0.000777	CcSEcCtD
Misoprostol—Abdominal pain—Epirubicin—testicular cancer	0.000425	0.000777	CcSEcCtD
Misoprostol—Hypersensitivity—Methotrexate—testicular cancer	0.000423	0.000774	CcSEcCtD
Misoprostol—Asthenia—Methotrexate—testicular cancer	0.000412	0.000754	CcSEcCtD
Misoprostol—Feeling abnormal—Doxorubicin—testicular cancer	0.00041	0.000749	CcSEcCtD
Misoprostol—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000407	0.000744	CcSEcCtD
Misoprostol—Hypersensitivity—Epirubicin—testicular cancer	0.000396	0.000724	CcSEcCtD
Misoprostol—Abdominal pain—Doxorubicin—testicular cancer	0.000393	0.000719	CcSEcCtD
Misoprostol—Body temperature increased—Doxorubicin—testicular cancer	0.000393	0.000719	CcSEcCtD
Misoprostol—Diarrhoea—Methotrexate—testicular cancer	0.000393	0.000719	CcSEcCtD
Misoprostol—Asthenia—Epirubicin—testicular cancer	0.000386	0.000705	CcSEcCtD
Misoprostol—Dizziness—Methotrexate—testicular cancer	0.00038	0.000695	CcSEcCtD
Misoprostol—Diarrhoea—Epirubicin—testicular cancer	0.000368	0.000672	CcSEcCtD
Misoprostol—Hypersensitivity—Doxorubicin—testicular cancer	0.000367	0.00067	CcSEcCtD
Misoprostol—Vomiting—Methotrexate—testicular cancer	0.000365	0.000668	CcSEcCtD
Misoprostol—Rash—Methotrexate—testicular cancer	0.000362	0.000662	CcSEcCtD
Misoprostol—Dermatitis—Methotrexate—testicular cancer	0.000362	0.000662	CcSEcCtD
Misoprostol—Headache—Methotrexate—testicular cancer	0.00036	0.000658	CcSEcCtD
Misoprostol—Asthenia—Doxorubicin—testicular cancer	0.000357	0.000652	CcSEcCtD
Misoprostol—Dizziness—Epirubicin—testicular cancer	0.000356	0.00065	CcSEcCtD
Misoprostol—Vomiting—Epirubicin—testicular cancer	0.000342	0.000625	CcSEcCtD
Misoprostol—Nausea—Methotrexate—testicular cancer	0.000341	0.000624	CcSEcCtD
Misoprostol—Diarrhoea—Doxorubicin—testicular cancer	0.00034	0.000622	CcSEcCtD
Misoprostol—Rash—Epirubicin—testicular cancer	0.000339	0.00062	CcSEcCtD
Misoprostol—Dermatitis—Epirubicin—testicular cancer	0.000339	0.000619	CcSEcCtD
Misoprostol—Headache—Epirubicin—testicular cancer	0.000337	0.000616	CcSEcCtD
Misoprostol—Dizziness—Doxorubicin—testicular cancer	0.000329	0.000601	CcSEcCtD
Misoprostol—Nausea—Epirubicin—testicular cancer	0.000319	0.000584	CcSEcCtD
Misoprostol—Vomiting—Doxorubicin—testicular cancer	0.000316	0.000578	CcSEcCtD
Misoprostol—Rash—Doxorubicin—testicular cancer	0.000314	0.000573	CcSEcCtD
Misoprostol—Dermatitis—Doxorubicin—testicular cancer	0.000313	0.000573	CcSEcCtD
Misoprostol—Headache—Doxorubicin—testicular cancer	0.000312	0.00057	CcSEcCtD
Misoprostol—Nausea—Doxorubicin—testicular cancer	0.000296	0.00054	CcSEcCtD
